Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Blog

  • Home
  •  
  • Blog



  • Most Read
  • Latest Comments
  • Blog
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Blog
    • Satire

    Australia to close borders to Omicron Persei 8
    Public
  • Blog
    • Opinion

    The New Criterion: will the listed sanitiser stocks clean up – or clean out – investors?
    Public
  • Blog
    • Opinion

    Is this the most hated company on the ASX?
    Public
  • Blog
    Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • AML3D announces stronger FY26, with positive EBITDA reported in the second half
    AML3D announces stronger FY26, with positive EBITDA reported in the second half
    • News

  • Refurbished tech gives Harris Technology a second life
    Refurbished tech gives Harris Technology a second life
    • News

  • Imagion Biosystems Advances MagSense® Phase 2 Trial
    Imagion Biosystems Advances MagSense® Phase 2 Trial
    • News

  • Acrux-developed Menopause Hormone Therapy to enter Australian market
    Acrux-developed Menopause Hormone Therapy to enter Australian market
    • News

  • Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    • News

  • Cash Converters acquires UK-based franchise Capital Cash for $24.7 million, hopes to set up European Hub
    • News

    Cash Converters acquires UK-based franchise Capital Cash for $24.7 million, hopes to set up European Hub

    Among the most satisfactory transactions is one that brings you financial returns for bygone items—old shoes, computers, and the like. You end up helping the environment, too by selling your old stuff instead of throwing them away. That’s why second-hand retail companies, like Cash Converters (ASX: CCV), catch consumers’ fancy.   To give a (further) leg

    Read More
    Public
  • Optiscan receives FDA feedback to pursue de novo pathway for oral imaging
    • News

    Optiscan receives FDA feedback to pursue de novo pathway for oral imaging

    Digital microscopic imaging company Optiscan (ASX: OIL) has gotten feedback from the US Food and Drug Administration (FDA) in relation to its Pre-Market Notification (510(k)) application for the InVivage product intended for oral tissue imaging. FDA’s regulatory clearance for the product requires that both the fluorescent contrast agent drug and the device used to visualise

    Read More
    Public
  • MMA wins $45m worth of contracts to support wind farm developments in Taiwan
    • News

    MMA wins $45m worth of contracts to support wind farm developments in Taiwan

    With the global offshore wind farm industry forecast to grow in the coming years, companies are getting in early to win big. Marine and subsea solutions company MMA Offshore (ASX: MRM) is one of them, having bagged three contracts to support offshore wind farm developments in Taiwan during 2023.  Spanning 370 days, the contracts will

    Read More
    Public
  • AFT’s pain relief medication Maxigesic gets FDA approval, but the IV version still under scrutiny
    • News

    AFT’s pain relief medication Maxigesic gets FDA approval, but the IV version still under scrutiny

    Maxigesic’s tagline goes: Put it to the test for your pain. Its maker—pharma company AFT Pharmaceuticals (ASX: AFP) —did indeed put the med to the test, and it came out as a winner, bagging FDA’s approval. Sort of like a super tablet, Maxigesic combines the powers of ibuprofen and paracetamol to create a super powerful

    Read More
    Public
  • ClearVue bags Hong Kong government contract for energy harvesting
    • News

    ClearVue bags Hong Kong government contract for energy harvesting

    At a time when companies are trying to become carbon neutral, smart technology companies are winning big. Making its first move into the Hong Kong market, smart building materials company, ClearVue Technologies (ASX: CPV), has been awarded a tender to conduct a measurement and verification study (M&V Study)—to understand how much energy it can save—in

    Read More
    Public
  • Can celebrity marketing save IOUPay and its BNPL decline?
    • News

    Can celebrity marketing save IOUPay and its BNPL decline?

    What started as a way to ease buyers’ financial stresses grew into one of their biggest stressors: Buy Now, Pay Later (BNPL). Bad debts and reckless spending has shined a light on the downsides of BNPL and its subsequent decline; yet, some digital payment service providers, like IOUPay (ASX: IOU), refuse to give up on

    Read More
    Public
  • «
  • ‹
  • 273
  • 274
  • 275
  • 276
  • 277
  • ›
  • »

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.